ASCO 2019 | Prostate Cancer: radiation with or without androgen-deprivation

Nicolas Magne

Nicolas Magne, MD, PhD, of the Lucien Neuwirth Oncology Institute, St-Priest-en-Jarez, France, tells us about the GETUG-AFU trial (NCT00423475), which investigated radiation therapy with or without goserelin in treating patients who have undergone surgery for recurrent or refractory prostate cancer. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Share this video  
Similar topics